PROTHENA (0769.859.405): financials and annual accounts

PROTHENA

Middelkerke ·KBO/BCE: BE 0769.859.405

Line	2025	2024	2023	2022
Balance sheet: assets
Total assets`20/58`	375	1,791	10,381	8,917
Fixed assets`21/28`	-	-	5,905	4,760
Intangible fixed assets`21`	-	-	1,653	2,193
Tangible fixed assets`22/27`	-	-	4,252	2,567
Plant, machinery and equipment`23`	-	-	3,112	1,047
Furniture and vehicles`24`	-	-	1,140	1,520
Current assets`29/58`	375	1,791	4,476	4,157
Amounts receivable within one year`40/41`	278	1,785	4,080	4,157
Trade receivables`40`	-	-	-	3,483
Other amounts receivable`41`	278	1,785	4,080	674
Cash at bank and in hand`54/58`	97	6	396	-
Balance sheet: equity and liabilities
Total equity and liabilities`10/49`	375	1,791	10,381	8,917
Equity`10/15`	-61,844	-61,598	-57,421	-30,367
Contributions`10/11`	3,000	3,000	3,000	3,000
Profit (loss) carried forward`14`	-64,844	-64,598	-60,421	-33,367
Amounts payable`17/49`	62,219	63,389	67,802	39,284
Amounts payable within one year`42/48`	62,219	63,389	67,802	39,284
Financial debts`43`	-	-	-	2
Credit institutions`430/8`	-	-	-	2
Trade debts`44`	101	-	11,351	5,473
Suppliers`440/4`	101	-	11,351	5,473
Taxes, remuneration and social security`45`	365	1,879	3,312	1,614
Taxes`450/3`	365	1,879	3,312	1,614
Other amounts payable`47/48`	61,753	61,510	53,139	32,195
Income statement
Non-recurring operating income`76A`	-	748	-	-
Gross operating margin`9900`	-10	-1,903	-24,355	-28,363
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets`630`	-	-	1,582	946
Other operating charges`640/8`	63	215	385	2,978
Non-recurring operating charges`66A`	-	1,653	-	-
Operating profit (loss)`9901`	-73	-3,771	-26,321	-32,287
Financial income`75/76B`	-	-	0	1
Recurring financial income`75`	-	-	0	1
Financial charges`65/66B`	90	124	161	389
Recurring financial charges`65`	90	124	161	389
Profit (loss) for the period before taxes`9903`	-163	-3,895	-26,483	-32,676
Income taxes`67/77`	82	282	571	691
Profit (loss) for the period`9904`	-246	-4,177	-27,054	-33,367
Profit (loss) for the period to be appropriated`9905`	-246	-4,177	-27,054	-33,367
Appropriation of the result
Profit (loss) to be appropriated`9906`	-64,844	-64,598	-60,421	-33,367
Profit (loss) brought forward from the previous period`14P`	-64,598	-60,421	-33,367	-
Document	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
30-06-2025	micro format	28-01-2026	2026-00019050	PDF
30-06-2024	micro format	31-01-2025	2025-00025060	PDF
30-06-2023	micro format	31-01-2024	2024-00015143	PDF
30-06-2022	micro format	30-01-2023	2023-00016216	PDF

Line	2025	2024	2023	2022
EBITDA	-	-	-24,739	-31,341
Cash flow	-	-	-25,472	-32,420
Investment in fixed assets	-	-	2,726	5,707
Change in cash	91	-390	-	-
Working capital	-61,844	-61,598	-63,326	-35,127
Solvency	-	-	-553.2%	-340.5%
Current ratio	-	-	0.07	0.11
ROA	-	-	-260.6%	-374.2%
Interest coverage	-	-	-153.25	-80.50

Item	30-06-2025	30-06-2024	30-06-2023	30-06-2022
Tangible fixed assets	-	-	€2,726	€3,006
Intangible fixed assets	-	-	-	€2,701
Depreciation and write-downs of the year	-	-	€1,582	€946

PROTHENA

Annual accounts 2025

Balance sheet

Change in equityin euro

Change in cashin euro

Position in the sector

Solvency-

Current ratio-

Return on assets-

Filed annual accounts

Filings

Key figures and ratios

Investments

Insights on PROTHENA

Next steps